Beckley Foundation

From WikiMD.org
Jump to navigation Jump to search

Beckley Foundation

The Beckley Foundation (pronounced: Beck-lee Foundation) is a UK-based think tank and UN-accredited NGO, dedicated to the global reform of drug policies and initiating scientific research into psychoactive substances. It was established in 1998 by Amanda Feilding.

Etymology

The name "Beckley Foundation" is derived from the location of its headquarters, Beckley Park, in Oxfordshire, England.

History

The Beckley Foundation was established in 1998 by Amanda Feilding, the Countess of Wemyss and March. Feilding, a long-time advocate for drug policy reform, founded the organization to further research into psychoactive substances and advocate for evidence-based, harm-reduction approaches to drug policy.

Research

The Beckley Foundation conducts and promotes multidisciplinary research on psychoactive substances. It aims to understand the effects of these substances on the brain, cognition, and society. The foundation's research has contributed to the understanding of the therapeutic potential of substances such as cannabis, psilocybin, and LSD.

Drug Policy Reform

The Beckley Foundation advocates for evidence-based drug policy reform. It works with global policy makers, including the United Nations and the World Health Organization, to promote harm-reduction approaches to drug policy. The foundation's policy work includes advocating for the decriminalization of drug use and the regulation of drug markets.

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski